Byondis mAb facility

Nijmegen, The Netherlands


The mAb plant is the third building realized from our masterplan for Byondis (previously Synthon BioPharmaceuticals). In this mAb plant, the company will produce pharmaceutical monoclonal antibodies.

Ir. Jan van Iersel
Ir. Renze Evenhuis
Saskia Kok

Project manager:
Ir. Willeke van der Groep

Constructional draughtsman:
Ing. Maarten van den Marel

Share this page